Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Amgen Inc

Recent news which mentions Amgen Inc

< Previous 1 2 3 Next >
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Investment strategy Amgen Inc US: News
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Exchange/traded funds Biotech and Pharmaceuticals Personal investing
From CNBC.com News
FDA approves Amgen's treatment for most deadly form of lung cancer
Tags Companies Breaking news Amgen Inc
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Viking Therapeutics Inc Business News Biotechnology
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets eBay Inc Berkshire Hathaway Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets Alphabet Inc Investing
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags US: News Business Amgen Inc
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Weight management Business News Catalent Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investing Markets Ford Motor Co
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Pharmaceuticals Bristol/Myers Squibb Co Biotechnology
From CNBC.com News
Top Wall Street analysts pick these stocks for solid returns
Tags Markets Investing Recursion Pharmaceuticals LLC
From CNBC.com News
Cramer lists his major themes for the market in 2024
Tags stocks Alphabet Inc Regeneron Pharmaceuticals Inc
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Biotech and Pharmaceuticals Health & Science AstraZeneca PLC
From CNBC.com News
Apple says longtime directors Al Gore and James Bell are retiring from the board
Tags Boeing Co Technology Amgen Inc
From CNBC.com News
Cramer says today's market is more interested in AI technology for advertising, not health-care solutions
Tags Investment Strategy Amgen Inc Business
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Bristol/Myers Squibb Co stocks Pfizer Inc
From CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
Tags Novartis AG Eli Lilly and Co Stock Picks
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Eli Lilly and Co Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios
Tags Nippon Steel Trading Corp Rite Aid Corp Investment Strategy
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Pharmaceuticals Pfizer Inc Health care industry
From CNBC.com News
Cramer's week ahead: Federal Reserve meeting, Apple and Eli Lilly earnings
Tags EOG Resources Inc Mad Money McDonald's Corp
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Tags Baxter International Inc Amgen Inc Business
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
Tags Humana Inc Plug Power Inc Amgen Inc
From CNBC.com News
Cramer analyzes last quarter's top 5 Dow performers
Tags Business News Stock markets Investment strategy
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Bristol/Myers Squibb Co Law and Regulation Novo Nordisk A/S
From CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
Tags Obesity Pfizer Inc Pharmaceuticals
From CNBC.com News
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
Tags Horizon Therapeutics PLC Companies Business
From CNBC.com News
FTC, Amgen strike deal to allow $27.8 billion Horizon Therapeutics acquisition to move forward
Tags Business News Breaking News: Business Health care industry
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.